| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |